Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Mapping cancer’s ‘social networks’ opens new approaches to treatment

Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.

Discovery could lead to more targeted drugs to stop cancer spread

Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP

BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner

BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.

Cancer Research UK increases investment in drug development

Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.

International deal to screen potential cancer drugs using DNA 'barcodes'

A screening technology tags compounds with strands of DNA to assess prototype drugs for anti-cancer activity.

Cancer Research UK and Lilly collaborate to trial combinations of potential new cancer treatments

Cancer Research UK's Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.

Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing

Senectus Therapeutics has signed a deal to screen a selection of AstraZenecaїs chemical compound library to identify those which trigger a key element of cancer cell...

CRT and AstraZeneca form major alliance to create cancer metabolism drugs

Cancer Research UKїs commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca...

Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**.